CN Patent
CN107200734B — 奎宁环衍生物及其制备方法和用途
Assigned to Yifang Biotechnology (Shanghai) Co.,Ltd. · Expires 2019-12-24 · 6y expired
What this patent protects
本发明涉及一种奎宁环衍生物及其药学上可接受的盐,前药和溶剂化合物及其制备方法,以及包含这些物质的药物组合物及其制药用途。本发明的化合物具有较好的M3受体拮抗剂活性,可以作为新型高效慢性阻塞性肺病的药物。
USPTO Abstract
本发明涉及一种奎宁环衍生物及其药学上可接受的盐,前药和溶剂化合物及其制备方法,以及包含这些物质的药物组合物及其制药用途。本发明的化合物具有较好的M3受体拮抗剂活性,可以作为新型高效慢性阻塞性肺病的药物。
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.